血液検査市場：製品タイプ、検査タイプ、サンプルタイプ、用途、エンドユーザー別-2025～2030年の世界予測

血液検査市場は、2024年には1,056億6,000万米ドルとなり、2025年には1,148億7,000万米ドル、CAGR 8.87%で成長し、2030年には1,760億3,000万米ドルに達すると予測されています。

血液検査は、正確な診断、治療計画、健康モニタリングを一貫してサポートする現代医療の要として台頭してきました。技術革新と進化する臨床需要が交錯する市場において、本レポートは、血液検査の展望を再定義する現在の動向、機会、課題を綿密に調査しています。近年、生化学的手法の進歩、デジタルデータの統合、サンプル処理の合理化により、精度、効率の向上、患者中心の医療という環境が整いつつあります。

本レポートでは、技術的な飛躍的進歩と市場力学の深い理解の組み合わせにより、従来の業務がどのように変化してきたかを包括的に考察しています。分析には定量調査と定性調査の両方が用いられており、意思決定者に、新たなイノベーションと実用的なアプリケーションのギャップを埋める実用的な洞察を提供しています。また、市場セグメンテーション、地域動向、競合力学に踏み込み、成長を促進する相互関連要因を解明しています。

医療が進化し続ける中、血液検査セグメントの複雑な開発に関する情報を入手することは、これまで以上に重要です。この採用は、検査手法の絶え間ない革新と改良に焦点を当てるだけでなく、この急速に進歩するセグメントの最前線であり続けることを目指す利害関係者に必要な戦略的必須事項を強調する詳細な議論の舞台を設定します。

血液検査の情勢を再定義する変革的シフト

近年、血液検査の環境を大きく変化させる変革的な変化が起きています。自動化、データ分析、先進的センサ技術の統合により、検査機器はより正確であるだけでなく、迅速な診断の要求に応えるのに適したものとなっています。並行して、デジタルデータ管理とソフトウェアソリューションの進化により、検査結果をより広範な患者の健康記録にシームレスに統合できるようになり、意思決定のスピードと精度の両方が強化されました。

このような進歩の多くは、精密医療が世界的に重視されるようになったことが背景にあります。そのため、検査機器はますます機敏になり、より迅速なターンアラウンドタイムを実現し、手作業にありがちな運用上の制約を減らしています。規制の枠組みも進化しており、臨床的妥当性と患者の安全性を高い水準で維持しながら、技術革新を奨励しています。

このセクションでは、技術と医療提供の間のダイナミックな相互作用を強調し、自動化の改善、データの相互運用性の向上、斬新な機器設計が、血液検査セグメントにおける患者ケアの全体的な水準を高めるためにどのように収束しつつあるかを説明します。これらの開発は、効率性の向上、市場競合の強化、画期的な研究開発と臨床応用の可能性を特徴とする、この産業の力強い未来を示唆しています。

包括的な市場セグメンテーションと詳細分析

血液検査市場は、消費者ニーズと技術進歩の両方の理解を深める豊富なセグメンテーションのタペストリーを示しています。製品による詳細な分析により、採血用品、先進的血液検査機器、必要不可欠な試薬と消耗品、データ管理ソリューションと統合されたソフトウェアを包含する構造が明らかになりました。特に、採血セグメントは、採血管、毛細血管採血器具、ランセット、見過ごされがちな注射器と針などの明確なカテゴリーにさらに分解されます。同様に、血液検査機器の領域は、生化学分析装置、凝固分析装置、血液学分析装置、免疫測定分析装置を含む様々な必須機器に分類されます。

市場セグメンテーションでは、製品タイプ以外にも、基礎代謝パネル、完全血球計数検査、完全代謝パネル、電解質パネルなどの検査タイプ別に分類されています。この区分により、利害関係者は診断効果や用途による性能を評価することができます。さらに、検体タイプによる区分は、動脈血検体、毛細血管検体、血漿または血清検体、静脈血検体を区別することで、プロセスの微妙な見方を記載しています。

市場需要を牽引する多様なアプリケーションを考慮すると、さらに深みが増します。アプリケーションによる専門的なセグメンテーションは、アレルギー診断、自己免疫疾患、がんと非がん性血液疾患、内分泌系疾患、心臓疾患にわたる活動に光を当てる。最後に、血液バンク、診断センター、病院クリニック、病理検査室など、主要な市場出口を扱うエンドユーザーセグメンテーションも重要です。これらの区分はそれぞれ、ユーザー固有のニーズに対する重要な洞察を提供し、ますます複雑化する医療環境において、製品・サービス開発へのテーラーメイドのアプローチを可能にします。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で早期診断と予防医療の需要が高まっている
    • ゲノミクスとバイオマーカーによる血液分析によってサポートされる個別化医療の導入拡大
    • ポイントオブケア検査施設の急速な拡大により、即時の診断結果へのアクセス性が向上
  • 抑制要因
    • 先進的血液検査設備に関連する高い生産コストと運用コスト
  • 機会
    • 先進的血液検査技術におけるAIと機械学習の統合
    • 技術革新のための研究開発への投資
  • 課題
    • 倫理的な懸念と患者の機密情報の潜在的な悪用
• 市場セグメンテーション分析
  • 検査タイプ：電解質の不均衡と腎機能を評価するための基礎代謝パネルの需要の高まり
  • エンドユーザー：安全な輸血を確保するために血液バンクで血液検査技術の利用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 血液検査市場：製品別

• イントロダクション
• 採血
  • 採血管（BCT）
  • 毛細管採血装置
  • ランセット
  • 注射器と針
• 血液検査装置
  • 生化学分析装置
  • 凝固分析装置
  • 血液分析装置
  • 免疫測定分析装置
• 試薬と消耗品
• ソフトウェアとデータ管理ソリューション

第7章 血液検査市場：検査タイプ別

• イントロダクション
• 基礎代謝パネル
• 全血球数検査
• 完全代謝パネル
• 電解質パネル

第8章 血液検査市場：サンプルタイプ別

• イントロダクション
• 動脈血サンプル
• 毛細血管血サンプル
• 血漿/血清サンプル
• 静脈血サンプル

第9章 血液検査市場：用途別

• イントロダクション
• アレルギー
• 自己免疫疾患
• がん/非がん性血液疾患
• 内分泌系疾患
• 心臓病

第10章 血液検査市場：エンドユーザー別

• イントロダクション
• 血液バンク
• 診断センター
• 病院とクリニック
• 病理学ラボ

第11章 南北アメリカの血液検査市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第12章 アジア太平洋の血液検査市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第13章 欧州・中東・アフリカの血液検査市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第14章 競合情勢

• 市場シェア分析、2024年
• FPNVポジショニングマトリックス、2024年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• A. Menarini Diagnostics s.r.l.
• Abbott Laboratories
• ACON Laboratories, Inc.
• ARKRAY, Inc.
• B. Braun Melsungen AG
• Becton Dickinson & Company
• Bio-Rad Laboratories Inc.
• BioMerieux SA
• Danaher Corporation
• F. Hoffmann-La Roche AG
• Johnson & Johnson Services, Inc.
• Medtronic PLC
• Merck KGaA
• Nipro Corporation
• Nova Biomedical Corporation
• Ortho Clinical Diagnostics, Inc.
• Quest Diagnostic
• Randox Laboratories Ltd.
• Siemens AG
• Terumo Corporation
• Thermo Fisher Scientific, Inc.
• Trinity BIoTech PLC
• Trividia Health, Inc.
• Ypsomed AG

LIST OF FIGURES

• FIGURE 1. BLOOD TESTING MARKET MULTI-CURRENCY
• FIGURE 2. BLOOD TESTING MARKET MULTI-LANGUAGE
• FIGURE 3. BLOOD TESTING MARKET RESEARCH PROCESS
• FIGURE 4. BLOOD TESTING MARKET SIZE, 2024 VS 2030
• FIGURE 5. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 6. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2024 VS 2030 (%)
• FIGURE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
• FIGURE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
• FIGURE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
• FIGURE 15. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 16. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
• FIGURE 17. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 18. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 19. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 20. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
• FIGURE 21. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 22. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 23. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 24. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
• FIGURE 25. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
• FIGURE 26. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 27. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. BLOOD TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL BLOOD TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BLOOD TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BLOOD TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION TUBES (BCTS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BLOOD TESTING MARKET SIZE, BY CAPILLARY BLOOD COLLECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BLOOD TESTING MARKET SIZE, BY LANCETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BLOOD TESTING MARKET SIZE, BY SYRINGES & NEEDLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BLOOD TESTING MARKET SIZE, BY BIOCHEMICAL ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BLOOD TESTING MARKET SIZE, BY COAGULATION ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BLOOD TESTING MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BLOOD TESTING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BLOOD TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BLOOD TESTING MARKET SIZE, BY SOFTWARE & DATA MANAGEMENT SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BLOOD TESTING MARKET SIZE, BY BASIC METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BLOOD TESTING MARKET SIZE, BY COMPLETE METABOLIC PANELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BLOOD TESTING MARKET SIZE, BY ELECTROLYTE PANELS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BLOOD TESTING MARKET SIZE, BY ARTERIAL BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BLOOD TESTING MARKET SIZE, BY CAPILLARY BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BLOOD TESTING MARKET SIZE, BY PLASMA/SERUM SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BLOOD TESTING MARKET SIZE, BY VENOUS BLOOD SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BLOOD TESTING MARKET SIZE, BY ALLERGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL BLOOD TESTING MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. GLOBAL BLOOD TESTING MARKET SIZE, BY CANCER/NONCANCEROUS BLOOD DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 36. GLOBAL BLOOD TESTING MARKET SIZE, BY ENDOCRINE SYSTEM DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 37. GLOBAL BLOOD TESTING MARKET SIZE, BY HEART DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 38. GLOBAL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. GLOBAL BLOOD TESTING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 40. GLOBAL BLOOD TESTING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 41. GLOBAL BLOOD TESTING MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 42. GLOBAL BLOOD TESTING MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 43. AMERICAS BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 44. AMERICAS BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 45. AMERICAS BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 46. AMERICAS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 47. AMERICAS BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 48. AMERICAS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. AMERICAS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. AMERICAS BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 51. ARGENTINA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 52. ARGENTINA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 53. ARGENTINA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 54. ARGENTINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 55. ARGENTINA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 56. ARGENTINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. ARGENTINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. BRAZIL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 59. BRAZIL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 60. BRAZIL BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 61. BRAZIL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 62. BRAZIL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 63. BRAZIL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. BRAZIL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. CANADA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 66. CANADA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 67. CANADA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 68. CANADA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 69. CANADA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. CANADA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. CANADA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. MEXICO BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 73. MEXICO BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 74. MEXICO BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 75. MEXICO BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 76. MEXICO BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MEXICO BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. MEXICO BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. UNITED STATES BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 80. UNITED STATES BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 81. UNITED STATES BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 82. UNITED STATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 83. UNITED STATES BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 84. UNITED STATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. UNITED STATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. UNITED STATES BLOOD TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 87. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 88. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 89. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 90. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 91. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. ASIA-PACIFIC BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 95. AUSTRALIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 96. AUSTRALIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 97. AUSTRALIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 98. AUSTRALIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 99. AUSTRALIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 100. AUSTRALIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. AUSTRALIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. CHINA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 103. CHINA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 104. CHINA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 105. CHINA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 106. CHINA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. CHINA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. CHINA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. INDIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 110. INDIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 111. INDIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 112. INDIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 113. INDIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 114. INDIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. INDIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. INDONESIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 117. INDONESIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 118. INDONESIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 119. INDONESIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 120. INDONESIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 121. INDONESIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. INDONESIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. JAPAN BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 124. JAPAN BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 125. JAPAN BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 126. JAPAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 127. JAPAN BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. JAPAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. JAPAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. MALAYSIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 131. MALAYSIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 132. MALAYSIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 133. MALAYSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 134. MALAYSIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 135. MALAYSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. MALAYSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. PHILIPPINES BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 138. PHILIPPINES BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 139. PHILIPPINES BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 140. PHILIPPINES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 141. PHILIPPINES BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 142. PHILIPPINES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. PHILIPPINES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. SINGAPORE BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 145. SINGAPORE BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 146. SINGAPORE BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 147. SINGAPORE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 148. SINGAPORE BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 149. SINGAPORE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. SINGAPORE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 152. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 153. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 154. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 155. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 156. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. SOUTH KOREA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. TAIWAN BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 159. TAIWAN BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 160. TAIWAN BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 161. TAIWAN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 162. TAIWAN BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 163. TAIWAN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. TAIWAN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. THAILAND BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 166. THAILAND BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 167. THAILAND BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 168. THAILAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 169. THAILAND BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 170. THAILAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. THAILAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. VIETNAM BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 173. VIETNAM BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 174. VIETNAM BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 175. VIETNAM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 176. VIETNAM BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 177. VIETNAM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. VIETNAM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 180. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 181. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 182. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 183. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 184. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. EUROPE, MIDDLE EAST & AFRICA BLOOD TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 187. DENMARK BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 188. DENMARK BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 189. DENMARK BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 190. DENMARK BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 191. DENMARK BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 192. DENMARK BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. DENMARK BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. EGYPT BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 195. EGYPT BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 196. EGYPT BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 197. EGYPT BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 198. EGYPT BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 199. EGYPT BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 200. EGYPT BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 201. FINLAND BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 202. FINLAND BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 203. FINLAND BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 204. FINLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 205. FINLAND BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 206. FINLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 207. FINLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 208. FRANCE BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 209. FRANCE BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 210. FRANCE BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 211. FRANCE BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 212. FRANCE BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 213. FRANCE BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. FRANCE BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 215. GERMANY BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 216. GERMANY BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 217. GERMANY BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 218. GERMANY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 219. GERMANY BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 220. GERMANY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. GERMANY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 222. ISRAEL BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 223. ISRAEL BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 224. ISRAEL BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 225. ISRAEL BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 226. ISRAEL BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 227. ISRAEL BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 228. ISRAEL BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 229. ITALY BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 230. ITALY BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 231. ITALY BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 232. ITALY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 233. ITALY BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 234. ITALY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 235. ITALY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 236. NETHERLANDS BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 237. NETHERLANDS BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 238. NETHERLANDS BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 239. NETHERLANDS BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 240. NETHERLANDS BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 241. NETHERLANDS BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 242. NETHERLANDS BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 243. NIGERIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 244. NIGERIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 245. NIGERIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 246. NIGERIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 247. NIGERIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 248. NIGERIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 249. NIGERIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 250. NORWAY BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 251. NORWAY BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 252. NORWAY BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 253. NORWAY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 254. NORWAY BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 255. NORWAY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. NORWAY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 257. POLAND BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 258. POLAND BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 259. POLAND BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 260. POLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 261. POLAND BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 262. POLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 263. POLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 264. QATAR BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 265. QATAR BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 266. QATAR BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 267. QATAR BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 268. QATAR BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 269. QATAR BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 270. QATAR BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 271. RUSSIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 272. RUSSIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 273. RUSSIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 274. RUSSIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 275. RUSSIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 276. RUSSIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 277. RUSSIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 278. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 279. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 280. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 281. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 282. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 283. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 284. SAUDI ARABIA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 285. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 286. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 287. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 288. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 289. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 290. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 291. SOUTH AFRICA BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 292. SPAIN BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 293. SPAIN BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 294. SPAIN BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 295. SPAIN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 296. SPAIN BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 297. SPAIN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 298. SPAIN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 299. SWEDEN BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 300. SWEDEN BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 301. SWEDEN BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 302. SWEDEN BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 303. SWEDEN BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 304. SWEDEN BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 305. SWEDEN BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 306. SWITZERLAND BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 307. SWITZERLAND BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 308. SWITZERLAND BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 309. SWITZERLAND BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 310. SWITZERLAND BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 311. SWITZERLAND BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 312. SWITZERLAND BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 313. TURKEY BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 314. TURKEY BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 315. TURKEY BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 316. TURKEY BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 317. TURKEY BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 318. TURKEY BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 319. TURKEY BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 320. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 321. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 322. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 323. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 324. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 325. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 326. UNITED ARAB EMIRATES BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 327. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
• TABLE 328. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY BLOOD COLLECTION, 2018-2030 (USD MILLION)
• TABLE 329. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY BLOOD TESTING INSTRUMENTS, 2018-2030 (USD MILLION)
• TABLE 330. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 331. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
• TABLE 332. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 333. UNITED KINGDOM BLOOD TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 334. BLOOD TESTING MARKET SHARE, BY KEY PLAYER, 2024
• TABLE 335. BLOOD TESTING MARKET, FPNV POSITIONING MATRIX, 2024

The Blood Testing Market was valued at USD 105.66 billion in 2024 and is projected to grow to USD 114.87 billion in 2025, with a CAGR of 8.87%, reaching USD 176.03 billion by 2030.

Blood testing has emerged as a cornerstone of modern healthcare, consistently supporting accurate diagnosis, treatment planning, and health monitoring. In a market where technological innovation and evolving clinical demands intersect, this report provides a meticulous exploration of current trends, opportunities, and challenges redefining the blood testing landscape. Over recent years, advances in biochemical methodologies, digital data integration, and streamlined sample processing have created a milieu of enhanced accuracy, efficiency, and patient-centric care.

This report offers a comprehensive look at how traditional practices have been transformed through a combination of technological breakthroughs and a deeper understanding of market dynamics. The analysis is grounded in both quantitative and qualitative research, providing decision-makers with actionable insights that bridge the gap between emerging innovations and practical applications. Throughout, the content delves into market segmentation, regional trends, and competitive dynamics, elucidating the interconnected factors driving growth.

As healthcare continues to evolve, staying informed about the intricate developments within the blood testing segment is more critical than ever. This introduction sets the stage for a detailed discussion that not only highlights the continuous innovations and refinements in testing methodologies but also emphasizes the strategic imperatives necessary for stakeholders aiming to remain at the forefront of this rapidly advancing field.

Transformative Shifts Redefining Blood Testing Landscape

Recent years have witnessed transformative shifts that are reshaping the blood testing environment in profound ways. The integration of automation, data analytics, and advanced sensor technologies has resulted in testing instruments that are not only more precise but also better suited to meet the demands of rapid diagnostic contexts. In parallel, the evolution of digital data management and software solutions now allows for seamless integration of testing results into broader patient health records, bolstering both decision-making speed and accuracy.

Many of these advancements have been driven by a global emphasis on precision medicine, where targeted treatments require granular, accurate patient datasets. As such, testing instruments are becoming increasingly agile, facilitating faster turnaround times and reducing the operational constraints typically associated with manual processes. Regulatory frameworks are also evolving, encouraging innovation while maintaining high standards of clinical validity and patient safety.

This section underscores the dynamic interplay between technology and healthcare delivery, illustrating how improved automation, enhanced data interoperability, and novel instrument designs are converging to elevate the overall standard of patient care within the blood testing sector. These developments signal a robust future for the industry, characterized by increased efficiency, heightened market competitiveness, and the potential for groundbreaking research and clinical applications.

Comprehensive Market Segmentation and Detailed Analysis

The blood testing market exhibits a rich tapestry of segmentation that enhances the understanding of both consumer needs and technological advancements. A detailed analysis based on products reveals a structure that encompasses blood collection supplies, sophisticated blood testing instruments, essential reagents and consumables, and integrated software alongside data management solutions. In particular, the blood collection segment is dissected further into distinct categories such as blood collection tubes, capillary blood collection devices, lancets, and the often-overlooked syringes and needles. Similarly, the realm of blood testing instruments is broken down into various essential devices including biochemical analyzers, coagulation analyzers, hematology analyzers, and immunoassay analyzers.

Beyond product classification, the market is also segmented according to test type where distinctions are made among basic metabolic panels, complete blood count tests, complete metabolic panels, and electrolyte panels. This division allows stakeholders to evaluate diagnostic efficacy and application-specific performance. Moreover, segmentation by sample type offers a nuanced view of the process, differentiating among arterial blood samples, capillary blood samples, plasma or serum samples, and venous blood samples.

Further depth is added when considering the varied applications driving market demand. Specialized segmentation based on application sheds light on activities across allergy diagnostics, autoimmune diseases, cancer and noncancerous blood disorders, endocrine system disorders, and heart diseases. Finally, an important consideration is the end-user segmentation, which addresses key market outlets including blood banks, diagnostic centers, hospitals and clinics, and pathology labs. Each of these segmentation categories offers critical insight into user-specific needs, enabling a tailored approach to product and service development in an increasingly complex healthcare environment.

Based on Products, market is studied across Blood Collection, Blood Testing Instruments, Reagents & Consumables, and Software & Data Management Solutions. The Blood Collection is further studied across Blood Collection Tubes (BCTs), Capillary Blood Collection Devices, Lancets, and Syringes & Needles. The Blood Testing Instruments is further studied across Biochemical Analyzers, Coagulation Analyzers, Hematology Analyzers, and Immunoassay Analyzers.

Based on Test Type, market is studied across Basic Metabolic Panels, Complete Blood Count Tests, Complete Metabolic Panels, and Electrolyte Panels.

Based on Sample Type, market is studied across Arterial Blood Samples, Capillary Blood Samples, Plasma/Serum Samples, and Venous Blood Samples.

Based on Application, market is studied across Allergies, Autoimmune Diseases, Cancer/Noncancerous Blood Disorders, Endocrine System Disorders, and Heart Diseases.

Based on End-User, market is studied across Blood Banks, Diagnostic Centers, Hospital & Clinics, and Pathology Labs.

Regional Landscape: Shifting Dynamics Across Global Markets

The global blood testing market is markedly influenced by regional dynamics, which profoundly affect market behavior and growth prospects. In the Americas, robust healthcare infrastructure and escalating demand for advanced diagnostic procedures drive innovation and consistent market expansion. This region has rapidly embraced modern technology, leading to improvements in diagnostic protocols and a growing emphasis on preventive care.

Across Europe, the Middle East, and Africa, the market is shaped by a blend of mature healthcare systems and emerging markets that are rapidly investing in modern diagnostic capabilities. These regions are witnessing an increase in public-private partnerships and research initiatives aimed at elevating healthcare outcomes. Stakeholders in these markets are increasingly leveraging advanced blood testing technologies to manage chronic diseases, thereby ensuring higher levels of reliability and timeliness in patient care.

In the Asia-Pacific region, rapid economic development, coupled with increased investment in healthcare infrastructure, has resulted in a burgeoning demand for state-of-the-art diagnostic tools. The region's emphasis on scalability and efficiency has spurred innovations within both public health institutions and private healthcare providers. Collectively, these geographical insights underscore the importance of adapting strategies to the unique economic, regulatory, and technological landscapes present in different regions, each contributing unique strengths and challenges to the overarching global blood testing narrative.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Market Leaders and Competitive Dynamics in Blood Testing

In an industry driven by technological advancements and relentless innovation, market leadership is defined by the ability to integrate cutting-edge research with pragmatic clinical applications. Prominent companies have distinguished themselves by deploying advanced diagnostic instruments and comprehensive data management systems that set new standards in precision and operational efficiency. Notable players have not only refined their product portfolios but have also embraced strategic partnerships that drive innovation. Among the market leaders, companies such as A. Menarini Diagnostics s.r.l. and Abbott Laboratories have consistently delivered robust solutions, while ACON Laboratories, Inc. and ARKRAY, Inc. expand their market presence with innovative diagnostic tools.

Other influential organizations, including B. Braun Melsungen AG and Becton Dickinson & Company, have made significant investments to ensure that their blood testing instruments remain at the forefront of technological advancement. Leaders in this sector such as Bio-Rad Laboratories Inc. and BioMerieux SA have leveraged their extensive research and development capabilities to introduce solutions that address both emerging health challenges and routine diagnostic needs. Crowned with further endorsements, Danaher Corporation and F. Hoffmann-La Roche AG have been instrumental in shaping industry standards through continual enhancements and strategic market positioning.

The competitive landscape is further enriched by the progressive contributions of Johnson & Johnson Services, Inc., Medtronic PLC, and Merck KGaA, who continue to prioritize innovation and reliability. Additional key companies such as Nipro Corporation, Nova Biomedical Corporation, Ortho Clinical Diagnostics, Inc., Quest Diagnostic, and Randox Laboratories Ltd. have carved out significant niches. The leadership of Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG further accentuates a market characterized by competitive rigor and rapid technological progression. Their diverse approaches and comprehensive portfolios provide a testament to a dynamic market where innovation, strategic investments, and global outreach combine to create lasting value for stakeholders.

The report delves into recent significant developments in the Blood Testing Market, highlighting leading vendors and their innovative profiles. These include A. Menarini Diagnostics s.r.l., Abbott Laboratories, ACON Laboratories, Inc., ARKRAY, Inc., B. Braun Melsungen AG, Becton Dickinson & Company, Bio-Rad Laboratories Inc., BioMerieux SA, Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Nipro Corporation, Nova Biomedical Corporation, Ortho Clinical Diagnostics, Inc., Quest Diagnostic, Randox Laboratories Ltd., Siemens AG, Terumo Corporation, Thermo Fisher Scientific, Inc., Trinity Biotech PLC, Trividia Health, Inc., and Ypsomed AG. Strategic and Actionable Recommendations for Industry Leaders

For industry leaders aiming to capitalize on evolving market trends, a set of strategic recommendations can serve as a roadmap for sustained competitive advantage. It is essential to prioritize technology integration, ensuring that advanced diagnostic instruments and data management systems are seamlessly incorporated into existing clinical workflows. Leaders should invest in research and development initiatives that focus on enhancing the precision and speed of blood testing processes while simultaneously reducing overall costs.

A key strategy involves fostering strong collaborative relationships across the supply chain. By integrating input from product developers, healthcare practitioners, and regulatory bodies, companies can accelerate the innovation cycle while ensuring that new products are both clinically relevant and market-ready. Additionally, embracing digital transformation through the adoption of artificial intelligence and machine learning technologies can significantly enhance data interpretation and operational decision-making, yielding improved patient outcomes.

Operational efficiency should also be a central pillar of any forward-looking strategy. This involves upgrading existing instrumentation and refining the processes associated with sample collection and testing. It is critical to optimize resource allocation by leveraging recent advancements in automation and remote diagnostics. Furthermore, expanding market footprint through targeted regional initiatives can help companies tap into emerging markets, particularly in regions where healthcare infrastructure is rapidly advancing.

In light of the competitive dynamics and competitive pressures in the market, it is crucial for leaders to maintain agility. By continually monitoring market trends and adopting proactive adjustments to their business models, industry players can ensure they remain at the leading edge of diagnostic innovation. This approach not only drives profitability but also enhances the capacity to deliver superior clinical care in the face of ever-evolving patient care demands.

Conclusion: Insights and Future Outlook

The blood testing market is clearly defined by its rapid evolution, technological advancements, and the unwavering demand for improved diagnostic precision. Concluding this exploration, the report brings together an analysis of transformative shifts, detailed market segmentation, regional dynamics, and competitive positioning among industry leaders. The insights reflect how innovation and strategic investments in research and development are reshaping clinical practices and enabling more accurate, efficient, and patient-centered care.

Ultimately, the convergence of advanced testing methodologies and digital integration paves the way for unprecedented growth opportunities. The interplay of market drivers underscores the importance of staying ahead of technological trends and regulatory changes. As the industry continues to mature, stakeholders who remain agile and strategically focused are well-positioned to benefit from emerging opportunities that redefine healthcare delivery and outcomes.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising demand for early diagnosis and preventive healthcare practices worldwide
    • 5.1.1.2. Growing adoption of personalized medicine supported by genomics and biomarker-based blood analysis
    • 5.1.1.3. Surging expansion of point-of-care testing facilities improving accessibility to immediate diagnostic results
  • 5.1.2. Restraints
    • 5.1.2.1. High production and operational costs linked with advanced blood testing equipment
  • 5.1.3. Opportunities
    • 5.1.3.1. Integration of AI and machine learning in advanced blood testing technologies
    • 5.1.3.2. Investments in research and development to innovate blood testing technologies
  • 5.1.4. Challenges
    • 5.1.4.1. Ethical concerns and potential misuse of sensitive patient information
• 5.2. Market Segmentation Analysis
  • 5.2.1. Test Type: Rising demand for basic metabolic panels for assessing electrolyte imbalance and renal function
  • 5.2.2. End-User: Growing usage of blood testing technologies in blood banks to ensure safe transfusions
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Blood Testing Market, by Products

• 6.1. Introduction
• 6.2. Blood Collection
  • 6.2.1. Blood Collection Tubes (BCTs)
  • 6.2.2. Capillary Blood Collection Devices
  • 6.2.3. Lancets
  • 6.2.4. Syringes & Needles
• 6.3. Blood Testing Instruments
  • 6.3.1. Biochemical Analyzers
  • 6.3.2. Coagulation Analyzers
  • 6.3.3. Hematology Analyzers
  • 6.3.4. Immunoassay Analyzers
• 6.4. Reagents & Consumables
• 6.5. Software & Data Management Solutions

7. Blood Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Basic Metabolic Panels
• 7.3. Complete Blood Count Tests
• 7.4. Complete Metabolic Panels
• 7.5. Electrolyte Panels

8. Blood Testing Market, by Sample Type

• 8.1. Introduction
• 8.2. Arterial Blood Samples
• 8.3. Capillary Blood Samples
• 8.4. Plasma/Serum Samples
• 8.5. Venous Blood Samples

9. Blood Testing Market, by Application

• 9.1. Introduction
• 9.2. Allergies
• 9.3. Autoimmune Diseases
• 9.4. Cancer/Noncancerous Blood Disorders
• 9.5. Endocrine System Disorders
• 9.6. Heart Diseases

10. Blood Testing Market, by End-User

• 10.1. Introduction
• 10.2. Blood Banks
• 10.3. Diagnostic Centers
• 10.4. Hospital & Clinics
• 10.5. Pathology Labs

11. Americas Blood Testing Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Blood Testing Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Blood Testing Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2024
• 14.2. FPNV Positioning Matrix, 2024
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Tasso and ARUP partner to revolutionize decentralized biomarker testing with at-home blood collection
  • 14.3.2. Curelo launch 10-minute doorstep blood testing service meets evolving consumer expectations
  • 14.3.3. Strand Life Sciences launches CancerSpot to revolutionize early cancer detection with advanced genomic sequencing and a state-of-the-art diagnostics research center
  • 14.3.4. Quest Diagnostics Introduces P-Tau217 Blood Biomarker for Alzheimer's Risk Assessment and Diagnostic Support
  • 14.3.5. Babson Diagnostics Launches Innovative Retail-Based Blood Testing Service
  • 14.3.6. Japan's Eisai Enhances Alzheimer's Detection with Strategic Investment in C2N Diagnostics
• 14.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. A. Menarini Diagnostics s.r.l.
• 2. Abbott Laboratories
• 3. ACON Laboratories, Inc.
• 4. ARKRAY, Inc.
• 5. B. Braun Melsungen AG
• 6. Becton Dickinson & Company
• 7. Bio-Rad Laboratories Inc.
• 8. BioMerieux SA
• 9. Danaher Corporation
• 10. F. Hoffmann-La Roche AG
• 11. Johnson & Johnson Services, Inc.
• 12. Medtronic PLC
• 13. Merck KGaA
• 14. Nipro Corporation
• 15. Nova Biomedical Corporation
• 16. Ortho Clinical Diagnostics, Inc.
• 17. Quest Diagnostic
• 18. Randox Laboratories Ltd.
• 19. Siemens AG
• 20. Terumo Corporation
• 21. Thermo Fisher Scientific, Inc.
• 22. Trinity Biotech PLC
• 23. Trividia Health, Inc.
• 24. Ypsomed AG